150 related articles for article (PubMed ID: 33454654)
1. Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo.
Dong S; Hu K; Shi Y; Wang G; Yu D; Zhao Y; Zhang H; Wang Y; Sun H; Xu Z; Jia Q; Li Y; Li Y; Li B; Shi J; Zhu W
Bioorg Med Chem Lett; 2024 Jan; 98():129590. PubMed ID: 38092072
[TBL] [Abstract][Full Text] [Related]
2. A systems biology approach reveals the role of a novel methyltransferase in response to chemical stress and lipid homeostasis.
Lissina E; Young B; Urbanus ML; Guan XL; Lowenson J; Hoon S; Baryshnikova A; Riezman I; Michaut M; Riezman H; Cowen LE; Wenk MR; Clarke SG; Giaever G; Nislow C
PLoS Genet; 2011 Oct; 7(10):e1002332. PubMed ID: 22028670
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways.
Naz F; Wu Y; Zhang N; Yang Z; Yu C
Molecules; 2020 Jul; 25(14):. PubMed ID: 32707651
[TBL] [Abstract][Full Text] [Related]
4. Paeonone A, a novel nonanortriterpenoid from the roots of Paeonia lactiflora.
Zhang JF; Li YC; Song YQ; Xia GY; Xia H; Wang YN; Tian GH; Ge GB; Lin S
Bioorg Chem; 2021 May; 110():104783. PubMed ID: 33714021
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology of cantharidin in cancer cells.
Rauh R; Kahl S; Boechzelt H; Bauer R; Kaina B; Efferth T
Chin Med; 2007 Jul; 2():8. PubMed ID: 17610718
[TBL] [Abstract][Full Text] [Related]
6. Cantharidin.
Am J Health Syst Pharm; 2023 Nov; 80(23):1686-1688. PubMed ID: 37703104
[No Abstract] [Full Text] [Related]
7. Exploring Cantharidin and its Analogues as Anticancer Agents: A Review.
Li S; Wu X; Fan G; Du K; Deng L
Curr Med Chem; 2023; 30(18):2006-2019. PubMed ID: 36330637
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma.
Yan J; Gao YM; Deng XL; Wang HS; Shi GT
BMC Cancer; 2023 Nov; 23(1):1161. PubMed ID: 38017425
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review.
Li Y; Deng X; Xiong H; Hu Q; Chen Y; Zhang W; Ma X; Zhao Y
Front Pharmacol; 2023; 14():1278014. PubMed ID: 37915415
[TBL] [Abstract][Full Text] [Related]
10. Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention.
Jin D; Huang NN; Wei JX
Front Pharmacol; 2023; 14():1201404. PubMed ID: 37383714
[TBL] [Abstract][Full Text] [Related]
11. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
Xu Y; Wang M; Ning S; Yang Z; Zhou L; Xia X
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296377
[TBL] [Abstract][Full Text] [Related]
12. New Evidence of Canthariphily: Tilloidea transversalis (Coleoptera: Cleridae) Sequestering Cantharidin From Lydus trimaculatus (Coleoptera: Meloidae).
Molfini M; Stefanuto L; Gisondi S; Gasperi T; Di Giulio A; Mancini E; Bologna MA
J Insect Sci; 2022 May; 22(3):. PubMed ID: 35762395
[TBL] [Abstract][Full Text] [Related]
13. Interaction of (+)-Strebloside and Its Derivatives with Na
Ren Y; Wu S; Chen S; Burdette JE; Cheng X; Kinghorn AD
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577146
[TBL] [Abstract][Full Text] [Related]
14. Structural Insights into the Interactions of Digoxin and Na
Ren Y; Wu S; Burdette JE; Cheng X; Kinghorn AD
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208576
[TBL] [Abstract][Full Text] [Related]
15. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
Ren Y; Kinghorn AD
Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
[TBL] [Abstract][Full Text] [Related]
16. Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?
McCuskey A; Keane MA; Mudgee LM; Sim AT; Sakoff J; Quinn RJ
Eur J Med Chem; 2000 Oct; 35(10):957-64. PubMed ID: 11121622
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
